MRNA vs TECH — Key Metrics
| Metric | MRNA (MODERNA INC) | TECH (BIO-TECHNE CORP) |
|---|---|---|
| Price | 192.57 | 72.47 |
| Market Cap | 76.88 Billion | 11.36 Billion |
| P/E (TTM) | -24.1 | 61.94 |
| P/B (Quarterly) | 3.237 | 5.385 |
| P/S (TTM) | 34.51 | 9.35 |
| Net Profit Margin (TTM) | -141.4 | 15.0 |
| Gross Margin (TTM) | 23.4 | 65.8 |
| ROE (TTM) | -39.2 | 8.9 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
MRNA · MODERNA INC
Greatly Underperform
TECH · BIO-TECHNE CORP
Greatly Underperform
Recommendation Summary
Both stocks are projected to greatly underperform the market over the next year. If you have to make a choice, Upfront Recommendation: MRNA.
Financial Metrics
Prices delayed ~15 min
| MRNA | Metrics | TECH |
|---|---|---|
| $192.57 | Price | $72.47 |
| — | Market Capitalization | — |
| 34.51 | Price to Sales | 9.35 |
| 147.56 | Price to Gross Profit | 14.22 |
| 26.73 | Price to R&D | 119.92 |
| 13.22 | Price to Current Assets | 15.27 |